Last year, after GlaxoSmithKline (GSK) was fined $3 billions, then signed the All Trials campaign, we were wondering if other pharmaceutical companies would follow GSK plans to share detailed clinical trial data online for researchers. What if “their selective transparency is a smokescreen for a wider, more nefarious agenda, which is further control” warns @Truthman30…
In his recent post, Dr. David Healy explains the following:
- Do academics have wild dreams? GSK thinks not
- Rain on the Parade
- The GSMA-ESK Model
- Patterns of Deception
- Have you been fucked by AllTrials?
- What can be done?
- Let’s Do the AbbVie Again